-
Symbol
-
CCCC on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.0001 per share
-
Latest Disclosed Shares Owned
-
6,060,000 shares
-
Security Ownership %
-
6.2%
BCLS II Equity Opportunities, LP ownership in C4 Therapeutics, Inc. Common Stock, par value $0.0001 per share (CCCC)
24 Oct 2025 - BCLS II Equity Opportunities, LP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,060,000 shares of C4 Therapeutics, Inc. Common Stock, par value $0.0001 per share (CCCC).
This represents 6.2% ownership of the company.
This is the first filing by Bain Capital Life Sciences Fund II, L.P. disclosing ownership of C4 Therapeutics, Inc. Common Stock, par value $0.0001 per share (CCCC).